As the pandemic still rages in many countries and bruised countries like the UK take their first steps to kick start the economy will we return to our normal reliance on the global supply chains? We business and the public look to buy products made closer to home, Buy British? Will the business be able to sustain the higher costs? The fragility of the global supply chain became very apparent as first China then India closed down and the pharma supply chain to most of the world was under threat. Britain has a pandemic and Brexit to deal with in the coming months and many of the companies who wish to supply the UK will be watching closely to see what the MHRA will announce in the coming months. The NHS keeps the costs of medicines in the UK down and therefore this is another consideration for suppliers is there enough margin, is it worth the effort should they focus on bigger markets. Over the past few months, the key UK suppliers have collaborated to ensure the efficient use of resources and to protect the fragile supply chain to maintain the supply of key medicines, sharing intelligence to ensure active substances and excipients were used wisely to prevent out of stock situations. It is unlikely that the UK will run a buy British for pharmaceuticals as the NHS probably cannot afford to.
Buy British, will the public shun Chinese products?
by Jackie (née Heneghan) Peck | Jun 25, 2020 | Blog
Recent Posts
Testimonials
Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training
Kim was helpful at answering all my questions and advise on how to do things independently or with the help of PCL.
Testimonial from a Pharmacist Trainee
Very informative. Thank you.
Katie Wenlock - Link Medical
Again, I stress how much I appreciate all your help, both today and through the whole journey of us striving to obtain our WDA(H).
Michael OgundeleAderemi Healthcare Ltd.
The course is very informative and comprehensive which covers all aspects of EU GDP guidelines.
Haidar Al-Bukhari
“Index the presentation to be able to reference quicker – detailed key acronyms. Good course, very enlightening for understanding and questioning current processes within our company.” Craig Buzzard – Course Rating 9/10
GDP & RP Training
Pharmacy Consulting have provided our business with excellent support, advice and training with regard to obtaining Wholesale Dealers Authorisation following the implementation of European Commission Guidelines of 5 November 2013 on Good Distribution Practice, 2013/C 343/01. I would like to personally thank Dawn and her team for her personal assistance in securing the authorisation.
Testimonial from Link Medical Limited, Bramshill
I want to thank you again for your successful presentation made in London to our Pharma Group Europe conference. Your detailed explanations for all the delegates were extremely interesting and enlightening. Our international participants from Germany, Austria, Switzerland and Romania expressed their praise and encouragement. Zdenek Schmittz- Pharma Group Europe
Testimonial from Zdenek Schmittz- Pharma Group Europe
“MHRA GDP guidelines are numerous and specific and potentially serious if not followed. The training went through each point in a common sense way, so the guidelines have appeared far more admirable and attainable.” Philip Hodgkinson – Course Rating 10/10
GDP Training
It was an absolute pleasure to meet with you and we are delighted given the extent of your contribution. There were many positive comments concerning your overall contribution. And as you are aware the workshops were exceptionally interesting for the audience. But also many colleagues made direct comments concerning your presentation which was rated as a highly clear and concise.
Ash Kay